| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV Infections | 86 | 2026 | 2586 | 14.980 |
Why?
|
| Anti-HIV Agents | 17 | 2025 | 486 | 7.060 |
Why?
|
| Florida | 78 | 2026 | 478 | 7.020 |
Why?
|
| Residence Characteristics | 22 | 2022 | 363 | 4.690 |
Why?
|
| Viral Load | 21 | 2025 | 348 | 4.480 |
Why?
|
| Minority Groups | 13 | 2025 | 690 | 3.370 |
Why?
|
| Medication Adherence | 8 | 2025 | 182 | 3.140 |
Why?
|
| Homosexuality, Male | 10 | 2025 | 486 | 2.970 |
Why?
|
| Adult | 89 | 2026 | 13872 | 2.640 |
Why?
|
| Healthcare Disparities | 10 | 2018 | 590 | 2.600 |
Why?
|
| Emigrants and Immigrants | 10 | 2021 | 158 | 2.560 |
Why?
|
| Humans | 145 | 2026 | 43102 | 2.520 |
Why?
|
| Professional-Patient Relations | 4 | 2025 | 60 | 2.440 |
Why?
|
| Female | 107 | 2026 | 24698 | 2.430 |
Why?
|
| Continuity of Patient Care | 7 | 2020 | 120 | 2.390 |
Why?
|
| Mass Screening | 13 | 2019 | 541 | 2.280 |
Why?
|
| Acquired Immunodeficiency Syndrome | 8 | 2024 | 226 | 2.270 |
Why?
|
| Haiti | 11 | 2025 | 86 | 2.200 |
Why?
|
| Adolescent | 56 | 2025 | 6081 | 2.190 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2025 | 497 | 2.100 |
Why?
|
| Poverty | 13 | 2024 | 400 | 2.080 |
Why?
|
| Male | 89 | 2026 | 23409 | 2.060 |
Why?
|
| Health Status Disparities | 7 | 2026 | 719 | 1.840 |
Why?
|
| Middle Aged | 55 | 2026 | 12222 | 1.810 |
Why?
|
| Young Adult | 43 | 2026 | 5080 | 1.780 |
Why?
|
| Patient-Centered Care | 2 | 2024 | 75 | 1.580 |
Why?
|
| Enterobacteriaceae Infections | 3 | 2021 | 12 | 1.530 |
Why?
|
| Depression, Postpartum | 3 | 2017 | 16 | 1.500 |
Why?
|
| Food Handling | 6 | 2010 | 35 | 1.470 |
Why?
|
| Qualitative Research | 7 | 2025 | 574 | 1.460 |
Why?
|
| Urban Population | 10 | 2021 | 374 | 1.410 |
Why?
|
| Population Surveillance | 10 | 2019 | 246 | 1.380 |
Why?
|
| Rural Health | 5 | 2016 | 55 | 1.380 |
Why?
|
| Stress, Psychological | 8 | 2025 | 661 | 1.350 |
Why?
|
| Anomie | 2 | 2021 | 6 | 1.330 |
Why?
|
| Health Education | 7 | 2019 | 363 | 1.310 |
Why?
|
| Prenatal Care | 4 | 2017 | 93 | 1.310 |
Why?
|
| United States | 28 | 2024 | 5205 | 1.230 |
Why?
|
| Delayed Diagnosis | 5 | 2017 | 38 | 1.190 |
Why?
|
| Retrospective Studies | 20 | 2025 | 2544 | 1.170 |
Why?
|
| Risk Factors | 27 | 2022 | 3994 | 1.150 |
Why?
|
| Rural Population | 9 | 2026 | 373 | 1.130 |
Why?
|
| Consumer Product Safety | 4 | 2008 | 10 | 1.080 |
Why?
|
| Vaccination | 9 | 2025 | 355 | 1.060 |
Why?
|
| Social Environment | 2 | 2019 | 218 | 1.060 |
Why?
|
| Public Assistance | 6 | 2010 | 26 | 1.030 |
Why?
|
| Substance-Related Disorders | 10 | 2024 | 830 | 1.030 |
Why?
|
| Socioeconomic Factors | 14 | 2024 | 1234 | 1.010 |
Why?
|
| Risk-Taking | 13 | 2020 | 457 | 1.000 |
Why?
|
| Cross-Sectional Studies | 19 | 2025 | 3156 | 1.000 |
Why?
|
| Trust | 2 | 2025 | 167 | 0.980 |
Why?
|
| Health Knowledge, Attitudes, Practice | 9 | 2024 | 989 | 0.940 |
Why?
|
| Logistic Models | 15 | 2019 | 1009 | 0.920 |
Why?
|
| Anti-Retroviral Agents | 5 | 2023 | 160 | 0.890 |
Why?
|
| Cause of Death | 5 | 2026 | 186 | 0.890 |
Why?
|
| Foodborne Diseases | 3 | 2010 | 23 | 0.880 |
Why?
|
| Prevalence | 12 | 2021 | 1612 | 0.870 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2019 | 117 | 0.870 |
Why?
|
| Physician-Patient Relations | 1 | 2025 | 148 | 0.850 |
Why?
|
| Bayes Theorem | 1 | 2024 | 126 | 0.810 |
Why?
|
| Depression | 3 | 2019 | 863 | 0.780 |
Why?
|
| Gonorrhea | 2 | 2021 | 24 | 0.770 |
Why?
|
| Food Services | 5 | 2010 | 33 | 0.760 |
Why?
|
| Physicians | 1 | 2024 | 188 | 0.720 |
Why?
|
| Social Class | 4 | 2018 | 291 | 0.710 |
Why?
|
| Delivery of Health Care | 3 | 2024 | 310 | 0.710 |
Why?
|
| Attitude of Health Personnel | 1 | 2024 | 231 | 0.710 |
Why?
|
| Alcohol Drinking | 4 | 2023 | 609 | 0.700 |
Why?
|
| Urban Health | 4 | 2016 | 101 | 0.690 |
Why?
|
| Odds Ratio | 10 | 2018 | 587 | 0.690 |
Why?
|
| Unsafe Sex | 5 | 2019 | 162 | 0.670 |
Why?
|
| Ambulatory Care Facilities | 4 | 2025 | 68 | 0.670 |
Why?
|
| Chlamydia | 1 | 2021 | 45 | 0.660 |
Why?
|
| Pregnancy | 14 | 2022 | 1772 | 0.660 |
Why?
|
| Infectious Disease Transmission, Vertical | 2 | 2019 | 74 | 0.630 |
Why?
|
| Triage | 1 | 2020 | 34 | 0.630 |
Why?
|
| Epidemiologic Methods | 1 | 2019 | 56 | 0.620 |
Why?
|
| Chlamydia Infections | 2 | 2019 | 200 | 0.600 |
Why?
|
| Asthma | 2 | 2017 | 416 | 0.600 |
Why?
|
| Parents | 2 | 2019 | 370 | 0.560 |
Why?
|
| Patient Compliance | 1 | 2020 | 233 | 0.560 |
Why?
|
| Health Services Accessibility | 6 | 2021 | 706 | 0.550 |
Why?
|
| Social Support | 4 | 2025 | 445 | 0.550 |
Why?
|
| Sexual Behavior | 8 | 2020 | 638 | 0.530 |
Why?
|
| Interpersonal Relations | 1 | 2019 | 222 | 0.520 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2017 | 12 | 0.520 |
Why?
|
| Child, Preschool | 12 | 2017 | 1546 | 0.520 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2017 | 15 | 0.510 |
Why?
|
| Risk Assessment | 5 | 2016 | 863 | 0.500 |
Why?
|
| Sexually Transmitted Diseases | 5 | 2018 | 174 | 0.500 |
Why?
|
| Mercury | 1 | 2017 | 39 | 0.500 |
Why?
|
| Infant, Newborn | 9 | 2022 | 972 | 0.500 |
Why?
|
| Life Change Events | 1 | 2016 | 109 | 0.480 |
Why?
|
| Infant | 11 | 2022 | 1175 | 0.480 |
Why?
|
| Environmental Exposure | 2 | 2017 | 256 | 0.480 |
Why?
|
| Death Certificates | 1 | 2015 | 15 | 0.470 |
Why?
|
| Sex Factors | 4 | 2026 | 1028 | 0.460 |
Why?
|
| Substance Abuse, Intravenous | 4 | 2020 | 129 | 0.450 |
Why?
|
| Multilevel Analysis | 4 | 2019 | 21 | 0.450 |
Why?
|
| Lead Poisoning | 2 | 2005 | 25 | 0.440 |
Why?
|
| Program Evaluation | 3 | 2020 | 359 | 0.440 |
Why?
|
| Health Personnel | 3 | 2024 | 277 | 0.430 |
Why?
|
| Child | 12 | 2019 | 3443 | 0.390 |
Why?
|
| beta-Lactamases | 3 | 2021 | 34 | 0.380 |
Why?
|
| Sexual Partners | 5 | 2021 | 326 | 0.380 |
Why?
|
| Early Detection of Cancer | 1 | 2017 | 449 | 0.380 |
Why?
|
| Cuba | 4 | 2019 | 33 | 0.360 |
Why?
|
| HIV | 2 | 2018 | 100 | 0.350 |
Why?
|
| Cross Infection | 3 | 2020 | 48 | 0.350 |
Why?
|
| Public Health Administration | 3 | 2009 | 26 | 0.350 |
Why?
|
| Housing | 3 | 2022 | 74 | 0.330 |
Why?
|
| Cohort Studies | 5 | 2021 | 1759 | 0.330 |
Why?
|
| Reproducibility of Results | 3 | 2024 | 1081 | 0.330 |
Why?
|
| Mental Health | 2 | 2025 | 385 | 0.320 |
Why?
|
| Maternal-Child Health Centers | 1 | 2010 | 4 | 0.320 |
Why?
|
| Aged | 14 | 2024 | 8214 | 0.320 |
Why?
|
| Proportional Hazards Models | 5 | 2016 | 518 | 0.320 |
Why?
|
| Caribbean Region | 3 | 2021 | 79 | 0.320 |
Why?
|
| Multimedia | 1 | 2010 | 18 | 0.320 |
Why?
|
| Neoplasms | 2 | 2019 | 1377 | 0.310 |
Why?
|
| Longitudinal Studies | 5 | 2019 | 1063 | 0.310 |
Why?
|
| Biomedical Research | 3 | 2021 | 502 | 0.310 |
Why?
|
| Age Factors | 5 | 2020 | 1154 | 0.310 |
Why?
|
| Demography | 3 | 2019 | 195 | 0.300 |
Why?
|
| Hepacivirus | 2 | 2007 | 74 | 0.300 |
Why?
|
| Voluntary Programs | 1 | 2009 | 4 | 0.300 |
Why?
|
| Antiretroviral Therapy, Highly Active | 3 | 2015 | 229 | 0.300 |
Why?
|
| Sentinel Surveillance | 1 | 2009 | 25 | 0.300 |
Why?
|
| Patient Satisfaction | 1 | 2010 | 165 | 0.290 |
Why?
|
| Awareness | 3 | 2018 | 73 | 0.290 |
Why?
|
| Disease Notification | 1 | 2008 | 5 | 0.280 |
Why?
|
| Self Efficacy | 3 | 2025 | 215 | 0.280 |
Why?
|
| Interviews as Topic | 3 | 2024 | 452 | 0.280 |
Why?
|
| Sex Distribution | 4 | 2015 | 224 | 0.280 |
Why?
|
| Hepatitis C Antibodies | 2 | 2007 | 10 | 0.280 |
Why?
|
| Communicable Disease Control | 1 | 2008 | 38 | 0.280 |
Why?
|
| Hepatitis B Vaccines | 2 | 2007 | 12 | 0.270 |
Why?
|
| Risk Reduction Behavior | 3 | 2019 | 138 | 0.270 |
Why?
|
| Students | 4 | 2018 | 626 | 0.270 |
Why?
|
| Survival Rate | 3 | 2014 | 355 | 0.270 |
Why?
|
| Refugees | 2 | 2005 | 21 | 0.270 |
Why?
|
| Health Policy | 2 | 2021 | 184 | 0.260 |
Why?
|
| Health Services Research | 1 | 2008 | 161 | 0.260 |
Why?
|
| Syphilis Serodiagnosis | 1 | 2006 | 7 | 0.260 |
Why?
|
| Safe Sex | 4 | 2020 | 78 | 0.250 |
Why?
|
| Hepatitis C, Chronic | 1 | 2007 | 44 | 0.250 |
Why?
|
| Syphilis | 1 | 2006 | 24 | 0.250 |
Why?
|
| Emergency Service, Hospital | 1 | 2009 | 278 | 0.250 |
Why?
|
| Bacterial Proteins | 2 | 2021 | 595 | 0.240 |
Why?
|
| Anti-Bacterial Agents | 3 | 2020 | 432 | 0.230 |
Why?
|
| Emigration and Immigration | 2 | 2006 | 85 | 0.230 |
Why?
|
| Incidence | 7 | 2015 | 1078 | 0.230 |
Why?
|
| Condoms | 5 | 2019 | 150 | 0.220 |
Why?
|
| Psychometrics | 2 | 2024 | 358 | 0.220 |
Why?
|
| Vital Statistics | 2 | 2017 | 7 | 0.220 |
Why?
|
| Cross-Cultural Comparison | 1 | 2024 | 111 | 0.220 |
Why?
|
| Perception | 2 | 2024 | 215 | 0.210 |
Why?
|
| Hepatitis B Surface Antigens | 1 | 2003 | 13 | 0.210 |
Why?
|
| Hepatitis B virus | 1 | 2003 | 18 | 0.210 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 174 | 0.210 |
Why?
|
| Hepatitis B | 1 | 2003 | 41 | 0.200 |
Why?
|
| Disclosure | 1 | 2023 | 39 | 0.200 |
Why?
|
| Canada | 1 | 2023 | 163 | 0.200 |
Why?
|
| Aged, 80 and over | 5 | 2017 | 2853 | 0.200 |
Why?
|
| Drug Users | 2 | 2024 | 52 | 0.200 |
Why?
|
| Diethylstilbestrol | 1 | 2023 | 11 | 0.200 |
Why?
|
| Latin America | 2 | 2021 | 55 | 0.190 |
Why?
|
| Research Personnel | 2 | 2021 | 206 | 0.190 |
Why?
|
| HIV Seropositivity | 2 | 2015 | 196 | 0.190 |
Why?
|
| South America | 2 | 2019 | 24 | 0.180 |
Why?
|
| Population Density | 2 | 2020 | 38 | 0.180 |
Why?
|
| Prediabetic State | 1 | 2022 | 69 | 0.180 |
Why?
|
| Administrative Personnel | 1 | 2021 | 11 | 0.170 |
Why?
|
| Time Factors | 3 | 2019 | 1857 | 0.170 |
Why?
|
| Mothers | 2 | 2016 | 215 | 0.170 |
Why?
|
| Intensive Care Units | 1 | 2021 | 72 | 0.170 |
Why?
|
| Career Mobility | 1 | 2021 | 29 | 0.170 |
Why?
|
| Motivation | 1 | 2025 | 513 | 0.170 |
Why?
|
| Mexico | 3 | 2017 | 298 | 0.170 |
Why?
|
| Information Dissemination | 1 | 2021 | 66 | 0.170 |
Why?
|
| Faculty, Medical | 1 | 2021 | 74 | 0.160 |
Why?
|
| Health Surveys | 3 | 2019 | 405 | 0.160 |
Why?
|
| Premature Birth | 1 | 2022 | 95 | 0.160 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 638 | 0.160 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 25 | 0.160 |
Why?
|
| Sex Characteristics | 1 | 2022 | 258 | 0.160 |
Why?
|
| Financing, Government | 1 | 2020 | 20 | 0.160 |
Why?
|
| Central America | 2 | 2017 | 13 | 0.160 |
Why?
|
| Comorbidity | 3 | 2019 | 737 | 0.160 |
Why?
|
| Educational Status | 3 | 2018 | 339 | 0.150 |
Why?
|
| Catheter-Related Infections | 1 | 2019 | 14 | 0.150 |
Why?
|
| Social Control, Informal | 1 | 2019 | 10 | 0.150 |
Why?
|
| Drug Evaluation | 1 | 2019 | 10 | 0.150 |
Why?
|
| Liver Diseases | 1 | 2019 | 34 | 0.150 |
Why?
|
| Drug Approval | 1 | 2019 | 10 | 0.150 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 29 | 0.150 |
Why?
|
| Health Promotion | 4 | 2017 | 704 | 0.150 |
Why?
|
| Tobacco, Smokeless | 1 | 2018 | 19 | 0.150 |
Why?
|
| Predictive Value of Tests | 1 | 2020 | 440 | 0.150 |
Why?
|
| Health Behavior | 2 | 2022 | 575 | 0.140 |
Why?
|
| Pyridones | 1 | 2019 | 50 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2019 | 103 | 0.140 |
Why?
|
| Alcohol-Related Disorders | 2 | 2016 | 63 | 0.140 |
Why?
|
| Mass Media | 2 | 2008 | 39 | 0.140 |
Why?
|
| Health Facility Environment | 1 | 2018 | 4 | 0.140 |
Why?
|
| Case Management | 1 | 2018 | 24 | 0.140 |
Why?
|
| Individuality | 1 | 2018 | 54 | 0.130 |
Why?
|
| Kidney Diseases | 1 | 2019 | 172 | 0.130 |
Why?
|
| Marketing | 1 | 2017 | 45 | 0.130 |
Why?
|
| Developing Countries | 1 | 2018 | 113 | 0.130 |
Why?
|
| Child Health Services | 2 | 2008 | 42 | 0.130 |
Why?
|
| Health Services Misuse | 1 | 2017 | 20 | 0.130 |
Why?
|
| Clinical Trials as Topic | 1 | 2019 | 259 | 0.130 |
Why?
|
| Spouses | 1 | 2017 | 38 | 0.130 |
Why?
|
| Public Health | 1 | 2021 | 424 | 0.130 |
Why?
|
| Adult Children | 1 | 2016 | 6 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2011 | 760 | 0.120 |
Why?
|
| Cardiovascular Diseases | 2 | 2019 | 749 | 0.120 |
Why?
|
| Puerto Rico | 2 | 2018 | 1413 | 0.120 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 64 | 0.120 |
Why?
|
| AIDS-Related Opportunistic Infections | 1 | 2015 | 44 | 0.120 |
Why?
|
| Behavior Therapy | 1 | 2017 | 180 | 0.120 |
Why?
|
| Early Diagnosis | 1 | 2015 | 68 | 0.120 |
Why?
|
| Poverty Areas | 1 | 2015 | 47 | 0.110 |
Why?
|
| Bariatric Surgery | 1 | 2015 | 23 | 0.110 |
Why?
|
| Child Abuse | 1 | 2016 | 92 | 0.110 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 376 | 0.110 |
Why?
|
| Minority Health | 1 | 2015 | 95 | 0.110 |
Why?
|
| Secondary Prevention | 1 | 2014 | 48 | 0.110 |
Why?
|
| Trinidad and Tobago | 2 | 2025 | 4 | 0.110 |
Why?
|
| Primary Prevention | 1 | 2014 | 63 | 0.110 |
Why?
|
| Confidence Intervals | 2 | 2011 | 162 | 0.110 |
Why?
|
| Diabetes Mellitus | 1 | 2019 | 539 | 0.100 |
Why?
|
| Age Distribution | 3 | 2019 | 249 | 0.100 |
Why?
|
| Postoperative Complications | 1 | 2015 | 263 | 0.100 |
Why?
|
| Mexican Americans | 1 | 2015 | 226 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2013 | 201 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2013 | 236 | 0.090 |
Why?
|
| Hypertension | 2 | 2017 | 835 | 0.090 |
Why?
|
| Mortality | 2 | 2011 | 175 | 0.090 |
Why?
|
| Survival Analysis | 1 | 2013 | 368 | 0.090 |
Why?
|
| United States Social Security Administration | 1 | 2011 | 4 | 0.090 |
Why?
|
| Workload | 1 | 2011 | 25 | 0.080 |
Why?
|
| Exercise | 1 | 2017 | 692 | 0.080 |
Why?
|
| Focus Groups | 2 | 2017 | 423 | 0.080 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 223 | 0.080 |
Why?
|
| Occupational Exposure | 1 | 2011 | 91 | 0.080 |
Why?
|
| Computer-Assisted Instruction | 1 | 2010 | 26 | 0.080 |
Why?
|
| Data Collection | 1 | 2010 | 210 | 0.080 |
Why?
|
| Food Contamination | 1 | 2010 | 57 | 0.080 |
Why?
|
| Nutritional Sciences | 1 | 2009 | 25 | 0.080 |
Why?
|
| Malawi | 2 | 2020 | 10 | 0.080 |
Why?
|
| Public Health Informatics | 1 | 2009 | 9 | 0.080 |
Why?
|
| Diarrhea | 1 | 2009 | 95 | 0.070 |
Why?
|
| Smoking Cessation | 1 | 2016 | 590 | 0.070 |
Why?
|
| Blood Glucose | 1 | 2011 | 389 | 0.070 |
Why?
|
| Communication | 2 | 2021 | 210 | 0.070 |
Why?
|
| Louisiana | 2 | 2019 | 50 | 0.070 |
Why?
|
| Education | 1 | 2008 | 60 | 0.070 |
Why?
|
| Program Development | 1 | 2009 | 240 | 0.070 |
Why?
|
| Feasibility Studies | 1 | 2009 | 259 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2008 | 207 | 0.070 |
Why?
|
| Universities | 2 | 2008 | 559 | 0.070 |
Why?
|
| Hepatitis A Vaccines | 1 | 2007 | 6 | 0.070 |
Why?
|
| School Health Services | 1 | 2008 | 90 | 0.070 |
Why?
|
| Caregivers | 1 | 2010 | 197 | 0.070 |
Why?
|
| Food Microbiology | 1 | 2007 | 39 | 0.060 |
Why?
|
| Medical Records | 1 | 2006 | 48 | 0.060 |
Why?
|
| Blood-Borne Pathogens | 2 | 2003 | 7 | 0.060 |
Why?
|
| Population Dynamics | 1 | 2006 | 50 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2008 | 575 | 0.060 |
Why?
|
| Maternal Health Services | 1 | 2006 | 23 | 0.060 |
Why?
|
| Video Recording | 1 | 2006 | 41 | 0.060 |
Why?
|
| Delivery, Obstetric | 1 | 2006 | 48 | 0.060 |
Why?
|
| Rubella Vaccine | 1 | 2006 | 2 | 0.060 |
Why?
|
| Rubella Syndrome, Congenital | 1 | 2006 | 2 | 0.060 |
Why?
|
| Guideline Adherence | 1 | 2006 | 98 | 0.060 |
Why?
|
| Counseling | 1 | 2007 | 138 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2009 | 760 | 0.060 |
Why?
|
| Postnatal Care | 1 | 2006 | 16 | 0.060 |
Why?
|
| Regression Analysis | 2 | 2018 | 490 | 0.060 |
Why?
|
| Community Health Services | 1 | 2006 | 206 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2022 | 1600 | 0.050 |
Why?
|
| Schools | 2 | 2017 | 283 | 0.050 |
Why?
|
| Disease Outbreaks | 2 | 2003 | 175 | 0.050 |
Why?
|
| Alcoholism | 1 | 2007 | 305 | 0.050 |
Why?
|
| Organ Transplantation | 1 | 2003 | 24 | 0.050 |
Why?
|
| Reverse Transcriptase Inhibitors | 1 | 2023 | 57 | 0.050 |
Why?
|
| Hospital Units | 1 | 2003 | 4 | 0.050 |
Why?
|
| Equipment Contamination | 1 | 2003 | 6 | 0.050 |
Why?
|
| Syringes | 1 | 2003 | 7 | 0.050 |
Why?
|
| Drug Resistance, Viral | 1 | 2023 | 67 | 0.050 |
Why?
|
| Salmonella Food Poisoning | 1 | 2002 | 1 | 0.050 |
Why?
|
| Child Welfare | 1 | 2003 | 49 | 0.050 |
Why?
|
| West Nile Fever | 1 | 2003 | 68 | 0.050 |
Why?
|
| Salmonella typhi | 1 | 2002 | 33 | 0.050 |
Why?
|
| West Nile virus | 1 | 2003 | 78 | 0.050 |
Why?
|
| Infant, Low Birth Weight | 1 | 2022 | 36 | 0.050 |
Why?
|
| Typhoid Fever | 1 | 2002 | 46 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2003 | 139 | 0.040 |
Why?
|
| Birth Weight | 1 | 2022 | 95 | 0.040 |
Why?
|
| Maryland | 1 | 2021 | 66 | 0.040 |
Why?
|
| Fruit | 1 | 2002 | 178 | 0.040 |
Why?
|
| Carbapenems | 1 | 2020 | 8 | 0.040 |
Why?
|
| Enterobacteriaceae | 1 | 2020 | 30 | 0.040 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 166 | 0.040 |
Why?
|
| Sample Size | 1 | 2019 | 28 | 0.040 |
Why?
|
| Philadelphia | 1 | 2019 | 20 | 0.040 |
Why?
|
| Hospitals | 1 | 2020 | 117 | 0.040 |
Why?
|
| Health Status | 1 | 2003 | 442 | 0.040 |
Why?
|
| Mutation | 1 | 2023 | 1177 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2019 | 122 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2017 | 52 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 341 | 0.030 |
Why?
|
| Registries | 1 | 2020 | 437 | 0.030 |
Why?
|
| Eritrea | 1 | 2017 | 1 | 0.030 |
Why?
|
| Government | 1 | 2017 | 8 | 0.030 |
Why?
|
| Medicine, Traditional | 1 | 2017 | 23 | 0.030 |
Why?
|
| Alabama | 1 | 2017 | 52 | 0.030 |
Why?
|
| Mandatory Programs | 1 | 2016 | 5 | 0.030 |
Why?
|
| Virginia | 1 | 2016 | 12 | 0.030 |
Why?
|
| South Carolina | 1 | 2016 | 25 | 0.030 |
Why?
|
| Random Allocation | 1 | 2016 | 147 | 0.030 |
Why?
|
| Tennessee | 1 | 2016 | 93 | 0.030 |
Why?
|
| Physician's Role | 1 | 2016 | 40 | 0.030 |
Why?
|
| Ambulatory Care | 1 | 2017 | 81 | 0.030 |
Why?
|
| Seasons | 1 | 2016 | 139 | 0.030 |
Why?
|
| Women's Health | 1 | 2017 | 160 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2019 | 1285 | 0.030 |
Why?
|
| Postoperative Care | 1 | 2015 | 20 | 0.030 |
Why?
|
| Family | 1 | 2017 | 195 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 1067 | 0.030 |
Why?
|
| Anxiety | 1 | 2021 | 874 | 0.020 |
Why?
|
| Censuses | 1 | 2013 | 28 | 0.020 |
Why?
|
| Income | 1 | 2013 | 160 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 2011 | 69 | 0.020 |
Why?
|
| Risk | 1 | 2011 | 287 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 667 | 0.020 |
Why?
|
| Child Nutrition Sciences | 1 | 2009 | 6 | 0.020 |
Why?
|
| Workplace | 1 | 2011 | 92 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 509 | 0.020 |
Why?
|
| Hygiene | 1 | 2009 | 14 | 0.020 |
Why?
|
| Nutrition Surveys | 1 | 2011 | 263 | 0.020 |
Why?
|
| Insulin | 1 | 2011 | 258 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2011 | 184 | 0.020 |
Why?
|
| Single Person | 1 | 2007 | 6 | 0.020 |
Why?
|
| Rubella | 1 | 2006 | 16 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2003 | 48 | 0.010 |
Why?
|
| Blood Donors | 1 | 2003 | 20 | 0.010 |
Why?
|
| Catheters, Indwelling | 1 | 2003 | 10 | 0.010 |
Why?
|
| Viremia | 1 | 2003 | 44 | 0.010 |
Why?
|
| Heart Transplantation | 1 | 2003 | 47 | 0.010 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2003 | 24 | 0.010 |
Why?
|
| Liver Transplantation | 1 | 2003 | 37 | 0.010 |
Why?
|
| Colorado | 1 | 2002 | 16 | 0.010 |
Why?
|
| Immunoglobulin M | 1 | 2003 | 86 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2003 | 54 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2003 | 53 | 0.010 |
Why?
|
| Physical Examination | 1 | 2003 | 45 | 0.010 |
Why?
|
| Morbidity | 1 | 2003 | 97 | 0.010 |
Why?
|
| Frozen Foods | 1 | 2002 | 1 | 0.010 |
Why?
|
| Honduras | 1 | 2002 | 8 | 0.010 |
Why?
|
| Guatemala | 1 | 2002 | 22 | 0.010 |
Why?
|
| Electrophoresis, Gel, Pulsed-Field | 1 | 2002 | 27 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2003 | 101 | 0.010 |
Why?
|
| Feces | 1 | 2002 | 132 | 0.010 |
Why?
|
| DNA, Bacterial | 1 | 2002 | 206 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 652 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2003 | 321 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2003 | 306 | 0.010 |
Why?
|
| Genotype | 1 | 2003 | 800 | 0.010 |
Why?
|